Home

RICHARD L SHARP

CIK 939448 · last filed 2011-11-28

RICHARD L SHARP is a corporate insider who has filed 39 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $243.9K of STSI on Nov 28, 2011. Across all open-market trades the lifetime net is −$75.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $118.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$118.08M

Companies

4

Total Filings

39

Lifetime Open-Market Net

-$75.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROCK CREEK PHARMACEUTICALS, INC. (STSI) Delisted Director 77,472 — — $243.9K 2 2011-11-28
CROX Director 676,756 $135.94 $92.00M -$41.71M 19 2011-07-01
FLEX Director 24,124 $113.28 $2.73M -$33.55M 17 2008-10-02
KMX 396,478 $58.88 $23.34M $0 1 2007-07-03

Recent Filings

39 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-11-28 ROCK CREEK PHARMACEUTICALS, INC. (STSI) Delisted Buy (P) +100,000 $243.9K EDGAR
2011-07-01 CROX Grant (A) +7,797 $0 EDGAR
2011-05-10 CROX Mixed −158,430 -$10.11M EDGAR
2011-03-21 ROCK CREEK PHARMACEUTICALS, INC. (STSI) Delisted Grant (A) — $0 EDGAR
2010-08-23 CROX Sell (S) −63,800 -$841.6K EDGAR
2010-08-19 CROX Sell (S) −352,900 -$4.71M EDGAR
2010-07-01 CROX Grant (A) +19,141 $0 EDGAR
2009-06-29 CROX Grant (A) +63,026 $0 EDGAR
2009-05-04 CROX Disp (D) — $0 EDGAR
2008-10-02 FLEX Grant (A) +14,124 $0 EDGAR
Showing 1–10 of 39
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.